Literature DB >> 4876427

Dates of onset of relapses and the duration of infection in induced tertian malaria with short and long incubation periods.

N A Tiburskaja, P G Sergiev, O S Vrublevskaja.   

Abstract

The course of induced tertian malaria has been studied in patients in psychoneurological hospitals in Moscow over a long period. Various strains of P. vivax were used to infect patients; the sporozoites were transmitted by Anopheles maculipennis atroparvus bred under laboratory conditions. There are marked differences between the dates of onset of relapses, reckoned from the primary manifestations of the disease, in patients developing malaria after long and short incubation periods. P. vivax strains which have a short incubation period are characterized by producing in patients a series of relapses following a long latent period; strains with a long incubation period are characterized by the occurrence of relapses during the first 3 months after the end of the primary series of attacks. However, some P. vivax strains give rise to both types of relapse, depending on the incubation period. In any event, the duration of the disease does not, as a rule, exceed 2 years, including the incubation period. The number of mosquitos (and hence the number of sporozoites) used to infect a patient does not have any noticeable effect on the number and frequency of relapses. In short-incubation tertian malaria, the use of quinocide during the period of treatment of the primary manifestations greatly reduced the number of relapses; in long-incubation tertian malaria similarly treated with quinocide, no relapses occurred.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4876427      PMCID: PMC2554493     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  [GROUPING OF P. VIVAX STRAINS BASED ON TYPES OF INCUBATION].

Authors:  N A TIBURSKAIA
Journal:  Med Parazitol (Mosk)       Date:  1964 Mar-Apr

2.  Natural history of Korean vivax malaria after deliberate inoculation of human volunteers.

Authors:  J ARNOLD; A S ALVING; R S HOCKWALD; C B CLAYMAN; R J DERN; E BEUTLER
Journal:  J Lab Clin Med       Date:  1954-11

3.  Relapses with Chesson strain Plasmodium vivax following treatment with chloroquine.

Authors:  G M JEFFERY
Journal:  Am J Trop Med Hyg       Date:  1956-01       Impact factor: 2.345

4.  Malaria during the last decade.

Authors:  M D YOUNG
Journal:  Am J Trop Med Hyg       Date:  1953-05       Impact factor: 2.345

5.  A contribution to the problem of strains of human plasmodium.

Authors:  P G SHUTE; M MARYON
Journal:  Riv Malariol       Date:  1954-06

6.  Studies in human malaria. XXX. A summary of 204 sporozoite-induced infections with the Chesson strain of Plasmodium vivax.

Authors:  G R COATNEY; W C COOPER; M D YOUNG
Journal:  J Natl Malar Soc       Date:  1950-12

7.  Studies in human malaria. XXVI. Simultaneous infection with the Chesson and the St. Elizabeth strains of Plasmodium vivax.

Authors:  W C COOPER; G R COATNEY; W B CULWELL; D E EYLES; M D YOUNG
Journal:  J Natl Malar Soc       Date:  1950-06

8.  [Description of strains of the causative agent of tertian malaria producing manifestations of the infection after a short incubation].

Authors:  N A Tiburskaia
Journal:  Med Parazitol (Mosk)       Date:  1965 Nov-Dec
  8 in total
  9 in total

1.  Geographical origin of Plasmodium vivax in the Republic of Korea: haplotype network analysis based on the parasite's mitochondrial genome.

Authors:  Moritoshi Iwagami; Seung-Young Hwang; Megumi Fukumoto; Toshiyuki Hayakawa; Kazuyuki Tanabe; So-Hee Kim; Weon-Gyu Kho; Shigeyuki Kano
Journal:  Malar J       Date:  2010-06-25       Impact factor: 2.979

Review 2.  Unstable vivax malaria in Korea.

Authors:  H I Ree
Journal:  Korean J Parasitol       Date:  2000-09       Impact factor: 1.341

3.  A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics.

Authors:  P C Garnham; R S Bray; L J Bruce-Chwatt; C C Draper; R Killick-Kendrick; P G Sergiev; N A Tiburskaja; P G Shute; M Maryon
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

4.  Plasmodium vivax blood-stage dynamics.

Authors:  F Ellis McKenzie; Geoffrey M Jeffery; William E Collins
Journal:  J Parasitol       Date:  2002-06       Impact factor: 1.276

Review 5.  Determinants of relapse periodicity in Plasmodium vivax malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2011-10-11       Impact factor: 2.979

6.  The rise and fall of long-latency Plasmodium vivax.

Authors:  N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-04-01       Impact factor: 2.184

7.  The global burden of Plasmodium vivax malaria is obscure and insidious.

Authors:  Katherine E Battle; J Kevin Baird
Journal:  PLoS Med       Date:  2021-10-07       Impact factor: 11.069

Review 8.  Experimental, therapeutic and natural transmission of Plasmodium vivax tertian malaria: scientific and anecdotal data on the history of Dutch malaria studies.

Authors:  Jan Peter Verhave
Journal:  Parasit Vectors       Date:  2013-01-18       Impact factor: 3.876

9.  Early efforts in modeling the incubation period of infectious diseases with an acute course of illness.

Authors:  Hiroshi Nishiura
Journal:  Emerg Themes Epidemiol       Date:  2007-05-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.